Cite

    Pina, T. et al. (2016). Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate‐to‐severe psoriasis undergoing anti‐tumor necrosis factor‐α therapy. Journal of dermatology. 43 (4), pp. 389-394. [Online].